Aileron Therapeutics and Pulmonary Care Experts To Discuss the Potential Implications of LTI-03 for Idiopathic Pulmonary Fibrosis in Virtual Key Opinion Leader Event tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Aileron Therapeutics to Host Key Opinion Leader Event on February 15, 2024 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON — Compared with dual therapies, a triple fixed-dose combination budesonide/glycopyrrolate/formoterol fumarate metered-dose inhaler showed more reductions in exacerbation rates across different COPD severity levels.This data was presented at the American Thoracic Society International Conference.
Get latest articles and stories on Health at LatestLY. A new tool shows promise in helping primary care physicians identify adults with undiagnosed chronic obstructive pulmonary disease (COPD), according to research published in JAMA. Health News | New Screening Tool Aims to Help in COPD Diagnosis.